CryoOx non-toxic intracellular cryoprotectant for cell cryopreservation and lyophilisation
CryoOx is a chemically modified saccharide-based cryoprotectant that enables intracellular delivery of protective sugars to improve cryopreservation and lyophilisation. Designed as a DMSO-free alternative, it supports cell viability, membrane integrity and cellular functionality across multiple cell types while simplifying cryopreservation workflows.
Applications: Cell cryopreservation and lyophilisation
| Features | Benefits |
|---|---|
| Chemically modified saccharide technology enabling intracellular uptake | Enables intracellular protection by delivering saccharides into cells |
| DMSO-free cryoprotectant platform designed to reduce toxicity concerns | Reduces post-thaw processing by removing the need for cryoprotectant removal |
| Suitable for both cryopreservation and lyophilisation applications | Eliminates the need for conventional toxic cryoprotectants such as DMSO in intended workflows |
| Preserves cell viability, membrane integrity and differentiation potential | Maintains critical cellular function following preservation |
| Demonstrated across multiple human and animal cell types | Broad platform potential for research, regenerative medicine and advanced cell therapy manufacturing |
| Compatible with straightforward, user-friendly cryopreservation protocols |
Patented and Available For
- Co-development
- Consulting
- Licensing